Date of event
Thursday, April 16, 2020 - 5:00 pm -
Thursday, April 16, 2020 - 6:00 pm
Continuing Education Credits

Content Contributor

AASLD COVID-19 Working Group


  • Ryan M. Kwok, MD
  • Michael L. Schilsky, MD, FAASLD
    Yale New-Haven Hospital

Moderator / Presenter

  • Elizabeth C. Verna, MD, MS
    Columbia University Medical Center


  • Kimberly Ann Brown, MD, FAASLD
    Henry Ford Health System
  • Jaime Chu, MD
    Icahn School of Medicine at Mount Sinai
  • Raymond T. Chung, MD, FAASLD
    Massachusetts General Hospital
  • Oren K. Fix, MD, MSc, FAASLD
    Swedish Medical Center
  • Patricia Harren, DNP
    Columbia University Medical Center
  • Laura M. Kulik, MD
    Northwestern University Feinberg School of Medicine
  • Brendan M. McGuire, MD
    University of Alabama at Birmingham


  • Jorge A. Bezerra, MD, FAASLD
    Cincinnati Children's Hospital Medical Center
  • Robert J. Fontana, MD, FAASLD
    University of Michigan Hospitals and Health
  • Bilal Hameed, MD
    University of California, San Francisco
  • David C. Mulligan, MD, FAASLD
    Yale University
  • Daniel S. Pratt, MD, FAASLD
    Massachusetts General Hospital
  • K. Rajender Reddy, MD, FAASLD
    University of Pennsylvania Medical Center
  • Mark W. Russo, MD, MPH, FAASLD
    Carolinas Medical Center


As the COVID-19 pandemic continues to evolve, AASLD is committed to helping our members and the broader community respond to increasing challenges and complexities.

This is the third in a series of webinars AASLD is dedicating to ongoing discoveries and discussions about COVID-19 and how it impacts the care of liver patients. This webinar:

  • Provides short synopses on several research articles.
  • Presents a few cases submitted in advance by attendees. The experts discuss the next best steps to be taken in that patient’s care.

Watch the Webinar / Download the Presentation


Download the slide presentation.

Presenter Bios

Ryan M. Kwok, MD

Dr. Ryan Kwok has authored more than 20 original articles, reviews, and book chapters. His research and collaboration interests include viral hepatitis and GI / Hepatology education. He has a special interest in the development of international medical research and education in developing countries with a focus on GI / Hepatology. He currently serves the AASLD on the Maintenance of Certification Committee and on the COVID-19 Working Group.

Photo of Dr. Kwok


Michael L. Schilsky, MD FAASLD

Michael L. Schilsky, MD FAASLD, became Medical Director of Liver Transplantation at Yale-New Haven Hospital in August 2007, and is Professor with appointments in the Departments of Medicine (Division of Digestive Diseases) and Surgery (Transplant and Immunology) at the Yale School of Medicine. He is the Fellowship Director for Transplant Hepatology and Director for the Center for Excellence for Wilson disease at Yale.

Dr. Schilsky received his medical degree from the University of Chicago, Pritzker School of Medicine (1982). He completed his residency (1985) and fellowship in gastroenterology (1987) and post-doctoral research training in liver diseases at the Albert Einstein College of Medicine and Montefiore Medical Center (1989). He became a full-time faculty member of the Division of Gastroenterology and member of the Liver Research Center at Einstein where he directed laboratory work on copper metabolism. In 1999 Dr. Schilsky joined the Division of Liver Disease at The Mount Sinai Medical Center and the Recanati/Miller Transplantation Institute as a transplant hepatologist. While at Mount Sinai he served as director of the Liver Medicine Clinic and started a clinic for patients with Wilson disease. In 2007 Dr. Schilsky became Medical Director for the Center for Liver Disease and Transplantation at the New York Weill Cornell Medical Center. While there he developed a comprehensive program for the care and evaluation of liver transplant patients and continued to expand his clinical and research efforts for patients with Wilson disease prior to his recruitment to Yale.

Dr. Schilsky’s clinical and research interests include transplant hepatology, acute liver failure and inherited metabolic disorders of the liver, in particular Wilson disease and hemochromatosis. Dr. Schilsky coauthored the AASLD and EASL practice guidelines for Wilson disease and is author of numerous original manuscripts and reviews. He is a member of the NIH Sponsored Acute Liver Failure Study Group. He currently serves as chair for the AASLD sponsored SIG on Transplant and Surgery.

photo of Dr. Schilsky


Moderator / Presenter Bio

Elizabeth C. Verna, MD, MS

Dr. Elizabeth Verna is an Associate Professor of Medicine in the Center for Liver Disease and Transplantation and Division of Digestive and Liver Diseases at Columbia University, where she practices as transplant hepatologist. In addition, Dr. Verna has an active clinical research program in end-stage liver disease and liver transplantation and is the Director of Clinical Research for the Columbia University Transplant Clinical Research Center.

photo of Dr. Elizabeth Verna